Sunday, October 12, 2014

Cardiac Manifestations of Friedreich Ataxia

›
Cardiac Manifestations of Friedreich Ataxia . Hari Krishnan NAIR, Cardiology Boston Children's Hospital, Published on October 12, 2014 ...
Saturday, October 11, 2014

The Diabetes Drug Target MitoNEET Governs a Novel Trafficking Pathway to Rebuild an Fe-S Cluster into Cytosolic Aconitase/Iron Regulatory Protein 1

›
The Diabetes Drug Target MitoNEET Governs a Novel Trafficking Pathway to Rebuild an Fe-S Cluster into Cytosolic Aconitase/Iron Regulatory Pr...
Friday, October 10, 2014

Horizon Pharma plc Announces Presentation of ACTIMMUNE(R) Phase 2 Data in Friedreich's Ataxia

›
Horizon Pharma plc Announces Presentation of ACTIMMUNE(R) Phase 2 Data in Friedreich's Ataxia . DUBLIN, IRELAND -- (Marketwired) -- 10/0...
Sunday, October 5, 2014

The roles of glutaredoxins ligating Fe–S clusters: Sensing, transfer or repair functions?

›
The roles of glutaredoxins ligating Fe–S clusters: Sensing, transfer or repair functions? ; Jérémy Couturier, Jonathan Przybyla-Toscano, Tho...

Trinucleotide expansion in disease: why is there a length threshold?

›
Trinucleotide expansion in disease: why is there a length threshold? . Do-Yup Lee, Cynthia T. McMurray; Current Opinion in Genetics & De...

Horizon Pharma plc Receives Orphan-Drug Designation for ACTIMMUNE(R) (Interferon gamma-1b) in Friedreich's Ataxia

›
Horizon Pharma plc Receives Orphan-Drug Designation for ACTIMMUNE(R) (Interferon gamma-1b) in Friedreich's Ataxia. Oct 03, 2014 (Market...
Friday, October 3, 2014

RTA 408 Capsules in Patients With Friedreich's Ataxia (MOXIe)

›
RTA 408 Capsules in Patients With Friedreich's Ataxia (MOXIe) . A Phase 2 Study of the Safety, Efficacy, and Pharmacodynamics of RTA 408...
Wednesday, October 1, 2014

Reata Announces the Initiation of Phase 2 Studies Examining RTA 408 for the Treatment of Friedreich's Ataxia and Mitochondrial Myopathies

›
Reata Announces the Initiation of Phase 2 Studies Examining RTA 408 for the Treatment of Friedreich's Ataxia and Mitochondrial Myopathie...
Monday, September 29, 2014

Comparing speech characteristics in spinocerebellar ataxias type 3 and type 6 with Friedreich ataxia

›
Comparing speech characteristics in spinocerebellar ataxias type 3 and type 6 with Friedreich ataxia . Bettina Brendel, Matthis Synofzik, ...

Idebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier?

›
Idebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier? . Sausan Jaber, Brian M. Polster; Journal of Bioenergetics an...